Comparing two methods for treating precancerous cervical lesions in women.
Official title: Comparison of cervical intraepithelial neoplasia 2/3 treatment outcomes with a portable LMIC-adapted thermal ablation device vs. gas-based cryotherapy
Funded at Cleveland Clinic Lerner Com-Cwru · NIH-10662503 · Data updated 2026-11-12
This study is looking at how well a new portable device for treating precancerous cervical lesions works compared to the usual gas-based method, especially for women in low- and middle-income countries, to help make effective and affordable treatments more accessible.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | January 12, 2018 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $490,168 |
| NIH project number | 5R01CA218195-06 |
| Project ID | NIH-10662503 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with cervical precancerous lesions, particularly in low- and middle-income countries.
✕Less likely to help
Patients who do not have cervical precancer or those living in high-income countries may not benefit from this research.
What this research studies
This research investigates the effectiveness of a new portable thermal ablation device compared to traditional gas-based cryotherapy for treating precancerous cervical lesions in women, particularly in low- and middle-income countries. The study aims to enhance access to affordable and effective treatment options by adapting existing technology for local use. By focusing on a point-of-care solution, the research seeks to improve treatment outcomes and reduce cervical cancer mortality rates. Patients will be monitored for treatment effectiveness and safety over time.
Why it matters
Potential benefit: If successful, this research could provide a more accessible and effective treatment option for women at risk of cervical cancer.
How similar studies have gone: Previous research has shown promise in using innovative treatment technologies for cervical precancer, but this specific approach is novel and tailored for LMICs.
Where this research is happening
-
Cleveland Clinic Lerner Com-Cwru
Cleveland, United States Active
Researchers
- Principal investigator: Cremer, Miriam — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Cremer, Miriam
Related research
Other NIH-funded projects on the same topics.
-
Point-of-care triage and thermal treatment for cervical precancer with the IRIS device
This project tests a portable thermal ablation device plus an AI image triage tool to treat and prioritize HPV-positive women aged 30–49 with cervical precancer in El Salvador.
-
HPV self-sampling to improve cervical screening for women in Zaporizhzhia during the war
This project will test whether giving women aged 30–60 in Zaporizhzhia HPV self-sampling kits can keep cervical screening going when clinic access is disrupted by the war.
-
Validation of a low-cost cervical cancer screening test
This study is testing a new, low-cost cervical cancer screening tool to see if it works as well as traditional methods for women in El Salvador.
-
HPV vaccination after treatment for cervical dysplasia
This study tests whether getting the HPV vaccine after treatment for cervical dysplasia can help prevent the return of HPV-related issues in women.
-
Using Fenofibrate to treat cervical cancer and dysplasia
This study is testing if Fenofibrate, a cholesterol-lowering drug, can help treat cervical cancer and pre-cancerous changes by trying to improve how cells work and slow down tumor growth.
-
Predicting how well imiquimod treatment works for cervical lesions
This study is testing if certain immune markers can help predict how well the treatment imiquimod works for people with high-grade cervical lesions.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.